 Voloridge Investment Management LLC bought a new stake in Myriad Genetics, Inc. NASDAQ:MYGN during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The institutional investor bought 30,217 shares of the companys stock, valued at approximately 432,000. A number of other institutional investors have ... 